Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 11:6:20628.
doi: 10.1038/srep20628.

Calcium and Magnesium Ions Are Membrane-Active against Stationary-Phase Staphylococcus aureus with High Specificity

Affiliations

Calcium and Magnesium Ions Are Membrane-Active against Stationary-Phase Staphylococcus aureus with High Specificity

Yuntao Xie et al. Sci Rep. .

Abstract

Staphylococcus aureus (S. aureus) is notorious for its ability to acquire antibiotic-resistance, and antibiotic-resistant S. aureus has become a wide-spread cause of high mortality rate. Novel antimicrobials capable of eradicating S. aureus cells including antibiotic-resistant ones are thus highly desired. Membrane-active bactericides and species-specific antimicrobials are two promising sources of novel anti-infective agents for fighting against bacterial antibiotic-resistance. We herein show that Ca(2+) and Mg(2+), two alkaline-earth-metal ions physiologically essential for diverse living organisms, both disrupt model S. aureus membranes and kill stationary-phase S. aureus cells, indicative of membrane-activity. In contrast to S. aureus, Escherichia coli and Bacillus subtilis exhibit unaffected survival after similar treatment with these two cations, indicative of species-specific activity against S. aureus. Moreover, neither Ca(2+) nor Mg(2+) lyses mouse red blood cells, indicative of hemo-compatibility. This works suggests that Ca(2+) and Mg(2+) may have implications in targeted eradication of S. aureus pathogen including the antibiotic-resistant ones.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Binding of M2+ (M = Ca, Mg) with cardiolipin (CL), the major lipid component in S. aureus, converts the originally zero-intrinsic-curvature (C0 ~ 0) lipid into M2+-CL complexes with negative intrinsic curvature (C0 < 0). (b–d) Dye leakage assays using large unilamellar vesicles (LUVs) composed of 100% CL as a first-order model for S. aureus membranes. (b) Mg2+ at ≥7.2 mM caused significant carboxyl fluorescein (CF) leakage. (c,d) Ca2+, though (c) unable to cause detectable CF leakage, caused (d) appreciable quenching in the fluorescence intensity of intravesicular lucigenin. Controls are samples assayed similarly but without M2+ additions.
Figure 2
Figure 2
(a,b) Dye leakage assays using DOPG: CL = 58:42 LUVs as a more realistic model for S. aureus membranes. Obviously, both (a) Mg2+ and (b) Ca2+ caused significant CF leakage from DOPG: CL = 58:42 LUVs and, to do so, their minimum threshold concentrations are 20 and 10 mM, respectively. Controls are samples assayed similarly but without M2+ addition.
Figure 3
Figure 3
Plate killing assays against stationary-phase cells of (a) S. aureus, (b) E. coli, and (c) B. subtilis. After 40-min co-incubation with Mg2+ (left) and Ca2+ (right) at ≤40 mM, S. aureus cells exhibited dose-dependent loss in viability. In contrast, the viability of E. coli and B. subtilis cells is barely impacted in similar assays. Data points are reported as mean ± standard deviation. *and** indicate p < 0.05 and p < 0.01, respectively.
Figure 4
Figure 4. Up to 40 mM, neither Mg2+ nor Ca2+ caused detectable hemolysis against mouse red blood cells.
Data points are reported as mean ± standard deviation.

Similar articles

Cited by

References

    1. Chambers H. F. & DeLeo F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629–641, doi: 10.1038/nrmicro2200. (2009). - DOI - PMC - PubMed
    1. Moore C. E., Segal S., Berendt A. R., Hill A. V. S. & Day N. P. J. Lack of association between toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 11, 1194–1197, doi: 10.1128/Cdli.11.6.1194-1197.2004 (2004). - DOI - PMC - PubMed
    1. Wertheim H. F. L. & Verbrugh H. A. Global prevalence of meticillin-resistant Staphylococcus aureus. Lancet 368, 1866 (2006). - PubMed
    1. Antibiotic Resistance Threats in the United States, 2013. Report by the U.S. Centers for Dieseas Control and Prevention.
    1. Shai Y. From Innate Immunity to de-Novo Designed Antimicrobial Peptides. Curr. Pharm. Des. 8, 715–725, doi: 10.2174/1381612023395367 (2002). - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources